RITTER PHARMACEUTICALS
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering a new frontier in human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into safe and effective applications that can have a meaningful impact on a patient’s health. Our pipeline of novel microbiome modulators ... selectively increase the growth of beneficial bacteria in the colonic ecosystem and create a meaningful impact on a patient’s health. Our first therapy, RP-G28, is currently under development for the treatment of lactose intolerance and has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease that affects over 1 billion people worldwide. RP-G28 has been studied in a Phase 2 clinical trial and is a first-in-class compound.
RITTER PHARMACEUTICALS
Industry:
Biotechnology Clinical Trials Health Diagnostics Medical Pharmaceutical Robotics
Founded:
2004-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.ritterpharma.com
Total Employee:
11+
Status:
Closed
Contact:
310-203-1000
Email Addresses:
[email protected]
Total Funding:
25.73 M USD
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email Stumbleupon Digg Del.icio.us
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Cotinga Pharmaceuticals
Cotinga Pharmaceuticals discovers and develops drug therapies for diseases.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Aspire Capital Partners LLC
Aspire Capital Partners LLC investment in Post-IPO Equity - Ritter Pharmaceuticals
Javelin Venture Partners
Javelin Venture Partners investment in Venture Round - Ritter Pharmaceuticals
Javelin Venture Partners
Javelin Venture Partners investment in Venture Round - Ritter Pharmaceuticals
Official Site Inspections
http://www.ritterpharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ritter Pharmaceuticals"
Ritter Pharmaceuticals - Crunchbase Company Profile & Funding
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering …See details»
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce
Jan 21, 2020 · Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat …See details»
Ritter Pharmaceuticals, Inc. | LinkedIn
Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the …See details»
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce ... - Nasdaq
Jan 21, 2020 · Ritter Pharmaceuticals, Inc. ( www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals Inc (RTTR) 10K Annual Reports & 10Q SEC …
Mar 31, 2020 · Ritter Pharmaceuticals, Inc. (www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals Selects Medpace as its Clinical
May 3, 2018 · It is a scientifically-driven organization with a dedicated in-house study team and clinical research physician support. Medpace has an extensive portfolio of successfully …See details»
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce Merger ...
Jan 21, 2020 · Ritter Pharmaceuticals, Inc. (www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals, Inc. Announces Expected Closing of
May 22, 2020 · Immediately following the closing, Ritter will be renamed “Qualigen Therapeutics, Inc.,” and is expected to trade on The Nasdaq Capital Market on a post-reverse stock split …See details»
Ritter Pharmaceuticals closes merger with Qualigen
May 23, 2020 · Ritter Pharmaceuticals' stockholders will own about 7.5% of the post-merger company while Qualigen investors will own the rest.See details»
Ritter Pharmaceuticals, Inc. Announces Adjournment of its Special …
May 14, 2020 · Ritter Pharmaceuticals, Inc. (www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals, Inc. (Ritter Pharmaceuticals, Inc.) - 药物管 …
RP-G28 is being investigated for treatment of moderate to severe lactose intolerance and its potential to improve the tolerance of lactose (dairy products). Background and Aims: Lactose …See details»
Ritter Pharmaceuticals & Qualigen Announce Merger Agreement
Ritter Pharmaceuticals, Inc. recently reported it has entered into a definitive reverse merger agreement with Qualigen, Inc. as well as expansion of its flagship FastPack diagnostic …See details»
Ritter Pharmaceuticals Regains Compliance with Nasdaq’s …
May 11, 2020 · Ritter Pharmaceuticals, Inc. (www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals Announces Phase 3 Plans ... - Pharma …
Ritter Pharmaceuticals, Inc. (www.RitterPharma.com, @RitterPharma) develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, …See details»
Ritter Pharmaceuticals Reports Financial Results for the First …
Ritter Pharmaceuticals, Inc. (RTTR) (“Ritter Pharmaceuticals”, Ritter” or the “Company”), a developer of therapeutic products that modulate the gut microbiome to treat gastrointestinal...See details»
Ritter Pharmaceuticals Selects Medpace as its CRO for Pivotal …
Ritter Pharmaceuticals, Inc. recently announced it has signed an agreement with the clinical research organization (CRO) Medpace to conduct the first of two pivotal Phase 3 clinical trials …See details»
Ritter Pharmaceuticals, Inc. and Qualigen, Inc. Announce
Jan 21, 2020 · Ritter Pharmaceuticals, Inc. ( www.RitterPharma.com, @RitterPharma) develops innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal …See details»
Ritter Pharmaceuticals Announces Phase 3 Plans after its End of …
Aug 18, 2017 · Ritter Pharmaceuticals, Inc. , a developer of novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases, today announced its …See details»
Andrew Ritter - CEO @ Docbot - Crunchbase Person Profile
Additionally, Andrew Ritter has had 2 past jobs including Founder & President at Ritter Pharmaceuticals. Andrew Ritter studied at University of Southern California and Stanford …See details»
Ritter (@RitterPharma) - Stocktwits
Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Our lead product, RP-G28, has the potential to …See details»